(Q43728694)

26 November 2017

title

Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression (English)

1 reference

26 November 2017

0 references

Parsey RV

1

1 reference

26 November 2017

Oquendo MA

2

1 reference

26 November 2017

Zea-Ponce Y

3

1 reference

26 November 2017

Rodenhiser J

4

1 reference

26 November 2017

Kegeles LS

5

1 reference

26 November 2017

Pratap M

6

1 reference

26 November 2017

Cooper TB

7

1 reference

26 November 2017

Van Heertum R

8

1 reference

26 November 2017

Mann JJ

9

1 reference

26 November 2017

Laruelle M

10

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

published in

Biological Psychiatry

1 reference

26 November 2017

volume

50

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

313-322

1 reference

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Negative symptoms in schizophrenia. Definition and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Dopamine D2 receptor density and personal detachment in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

7 January 2021

Dopamine and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Dopamine D2 receptors in depression measured with single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

The role of dopamine in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Dopamine and depression--striatal dopamine D2 receptor SPECT before and after antidepressant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

D2 dopamine receptors and personality traits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Role of the dopaminergic system in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Striatal dopamine transporter density in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Increased dopamine transmission in schizophrenia: relationship to illness phases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Imaging D2 receptor occupancy by endogenous dopamine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

From motivation to action: functional interface between the limbic system and the motor system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Low dopamine D(2) receptor binding potential in social phobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Reward processing in primate orbitofrontal cortex and basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Clinical and psychometric correlates of dopamine D2 binding in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Prediction of imipramine antidepressant response by a one-day dextro- amphetamine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Imaging studies of cocaine in the human brain and studies of the cocaine addict

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Chronic mild stress-induced anhedonia: a realistic animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Brain dopamine and reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Rapid Automated Algorithm for Aligning and Reslicing PET Images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

Synthesis of [123I]IBZM: a reliable procedure for routine clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901089-7

10.1016/S0006-3223(01)01089-7

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference